Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial

AIMS: Current guidelines recommend stopping oral anticoagulation (OAC) and starting heparin infusion before implanting/replacing a pacemaker/implantable cardioverter-defibrillator (ICD) in patients with high risk for thrombo-embolic events. The aim of this study was to demonstrate that the maintenan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolosana, Jose M., Berne, Paola, Mont, Lluis, Heras, Magda, Berruezo, Antonio, Monteagudo, Joan, Tamborero, David, Benito, Begoña, Brugada, Josep
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719698/
https://www.ncbi.nlm.nih.gov/pubmed/19487235
http://dx.doi.org/10.1093/eurheartj/ehp194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719698/
https://www.ncbi.nlm.nih.gov/pubmed/19487235
http://dx.doi.org/10.1093/eurheartj/ehp194

Ejemplares similares